stock market stocks

Is Facebook Inc stock a good buy near its all-time high price?

Shares of Menlo Park, California-basedFacebook Inc.(NASDAQ:FB)are on a roll in 2017, gaining more than 21% YTD after a lackluster 2016. FB stock is trading near its all-time high of $139.68. FB stock has been driven by multiple factors. At large, the strong bullish rally has been on account of strong revenue growth and higher profits which Facebook registered in 2016.Facebook Inc hadreported 54% growth in revenue for 2016. However, in its Q4 earnings call, the management warned investors that the social media giant could face strong headwinds on the growth front as “ad load” had saturated. But if you go by some latest research, the Menlo Park company is set to increase its grip on the digital ad market. With FB stock near its all-time highs, the question is whether it will continue to move higheror not? Here is another reason why FB stock is a buy, even near its all-time high.

stock market stocks: Senior Housing Properties Trust(SNH)

Advisors’ Opinion:

  • [By Matthew Frankel]

    Healthcare real estate is just as defensive of an investment as net-lease retail, and has even more growth potential in the years ahead. One beaten-down healthcare REIT that I have my eye on in 2017 is Senior Housing Properties Trust (NASDAQ:SNH).

stock market stocks: Humana Inc.(HUM)

Advisors’ Opinion:

  • [By Lee Jackson]

    Health care giant Humana Inc. (NYSE: HUM) had a director and the chief operating officer of the company selling stock last week. The director sold 27,000 shares at prices between $204.51 and $206.43. The total for the sale was $7 million. COO Jim Murray sold 122,571 shares at prices that ranged from $204.231 to $206. The total for his trade was posted at $25 million. Shares closed on Friday at $207.28. The 52-week range is $150 to $217.80, and the consensus price target is $223.21.

  • [By Keith Speights]

    Although Aetna wasn’t successful in its attempted merger with Humana (NYSE:HUM), the blocked deal shouldn’t have too much residual effect. Aetna’s share price remains attractively valued, currently trading at 13 times expected earnings.

  • [By Ben Levisohn]

    How good were UnitedHealth Group’s (UNH) earnings today? So good its stock has jumped the most in more than six years–and lifted competitors like Humana (HUM), Cigna (CI), Aetna (AET), and Anthem (ANTM) as well. Leerink’s Ana Gupte explains why the market is in love with UnitedHealth’s earnings:

  • [By Ben Levisohn]

    The Wall Street Journal reported that government regulators are pushing back against Anthem’s (ANTM) purchase of Cigna (CI). California, however, seems to have few issues with the proposed combination of Aetna (AET) andHumana (HUM). Leerink’s Ana Gupte explains:

  • [By David Zeiler]

    Aetna is the focus of the senators’ wrath, but four of the five largest U.S. health insurers have a stake in this fight:

    No. 3 Aetna is attempting to acquire No. 5 Humana Inc. (NYSE: HUM); andNo. 2 Anthem Inc. (NYSE: ANTM) is seeking to acquire No. 4 Cigna Corp. (NYSE: CI).

    Related: Why the Cost of Obamacare Plans Will Continue to Skyrocket

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Tuesday was Humana Inc. (NYSE: HUM) which jumped 2.4% to $217.76. The gain was following news that Trump had endorsed the House Republican health care plan. Also Humana is teaming up with Quartet to deliver integrated mental health care to New Orleans residents. The stocks 52-week range is $150.00 to $218.92. Volume was about 26% above the daily average of around 1.7 million shares.

stock market stocks: Contango Oil & Gas Company(MCF)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Thursday, energy shares were relative laggards, down on the day by about 0.87 percent. Meanwhile, top losers in the sector included NGL Energy Partners LP (NYSE: NGL), down 17 percent, and Contango Oil & Gas Company (NYSE: MCF), down 12 percent.

stock market stocks: Sharp Corp (SHCAF)

Advisors’ Opinion:


    The company is partnering with Chinese company OXi Technology (in which it also made a strategic investment) for developing fingerprint sensor under glass and in the bezel of smartphones. Its fingerprint sensor business received a boost from the Samsung (OTC:SSNLF) S8 and S8+ design wins (as well as Sharp’s (OTCPK:SHCAF) Aquos R and ZTE ZMax Pro).

stock market stocks: Boot Barn Holdings, Inc.(BOOT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Boot Barn Holdings Inc (NYSE: BOOT) shares dropped 15 percent to $6.30. Boot Barn reported weaker-than-expected results for its fourth quarter.

    Shares of Endocyte, Inc. (NASDAQ: ECYT) were down 31 percent to $1.89 after the company issued clinical updates for EC1456 and EC1169, and announced plans to reduce workforce by 40 percent via restructuring. Endocyte said that it is continuing EC1169 program in taxane-exposed patients, but ending clinical development of EC1456 and EC1169 in taxane-na茂ve patients.

stock market stocks: Spark Therapeutics, Inc.(ONCE)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Wednesday, our Elite Opportunity Pronewsletter suggested going long again on small cap gene therapy stock Spark Therapeutics (NASDAQ: ONCE):

    Financially, Spark Therapeutics has over $300M in cash on the books and no debt to speak of yet, which equates to a share price of just over four times cash. The Company has generated over $20M in revenue for the trailing twelve months, and although the Company is expected to continue to lose money for the next few years, any strong clinical data that hits the tape could rocket shares of ONCE overnight, just like we’ve seen with so many others over the years.

Leave a Reply

Your email address will not be published. Required fields are marked *